r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

PV

Paul Maier V

Insider · Director · ETON

Paul Maier V files insider transactions with the SEC as a director of Eton Pharmaceuticals (ETON). We hold 2 disclosed purchases and sales filed since 14 March 2006, 2 of them in the last 90 days.

  • Files forETON
  • Disclosed buys and sells2 in all, 2 in the last 90 days
  • Last disclosure31 August 2026

Positions held

12 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 15 November 2018 — 28 August 2026Director · Eton Pharmaceuticals (ETON)25 Form 4 lines · source: SEC Form 4
  • Filed 10 December 2009 — 17 June 2025Director · International Stem Cell (ISCO.OB)66 Form 4 lines · source: SEC Form 4
  • Filed 27 January 2023 — 7 March 2024Director · Ambrx Biopharma (AMAM)8 Form 4 lines · source: SEC Form 4
  • Filed 13 October 2015 — 15 January 2020Director · Ritter Pharmaceuticals (RTTR)5 Form 4 lines · source: SEC Form 4
  • Filed 2 April 2015 — 2 April 2018Director · Mabvax Therapeutics Holdings (MBVX)24 Form 4 lines · source: SEC Form 4
  • Filed 1 June 2012 — 4 January 2018Director · Apricus Biosciences (APRI)11 Form 4 lines · source: SEC Form 4
  • Filed 20 July 2007 — 31 December 2015Director · International Stem Cell (ISCO)10 Form 4 lines · source: SEC Form 4
  • Filed 20 January 2010 — 10 February 2014Chief Financial Officer · Sequenom (SQNM)55 Form 4 lines · source: SEC Form 4
  • Filed 1 April 2011 — 17 July 2013Director · Talon Therapeutics (TLON)11 Form 4 lines · source: SEC Form 4
  • Filed 9 April 2008 — 31 July 2012Director · Pure Bioscience (PURE)6 Form 4 lines · source: SEC Form 4
  • Filed 13 March 2008 — 16 February 2010Director · Hana Biosciences (HNAB)5 Form 4 lines · source: SEC Form 4
  • Filed 10 March 2006 — 20 November 2006Sr. V-P, CFO · Ligand Pharmaceuticals (LGND)137 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.